Article | August 19, 2021

Meeting Oligo System Development Challenges Head-On

By Steve Foy, Product Marketing Manager, Asahi Kasei Bioprocess America

Oligo System

Asahi Kasei Bioprocess America (AKBA) is devoted to solving therapeutic product safety, efficiency and purity challenges within the pharmaceutical and bioprocessing industries.

By focusing our expertise on fluid management technology, our portfolio of market-driven equipment and cutting-edge technology touches unit operations across a wide range of therapeutic modalities, including classical small molecule pharmaceuticals, current-generation antibodies, plasma derivatives and next-generation oligonucleotide therapeutics.

The GEMÜ Group is a family-owned, leading manufacturer of valves, measurement and control systems for liquids, vapors and gases – as well as a global market leader in sterile application solutions.

Read more how this partnership is redefining what is possible in oligonucleotide manufacturing.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: